PET/CT with 89Zr-trastuzumab and 18F-FDG to individualize treatment with trastuzumab emtansine (T-DM1) in metastatic HER2-positive breast cancer (mBC).
Abstract
Data di Pubblicazione:
2014
Tipologia CRIS:
1.5 Abstract in rivista
Elenco autori:
Gebhart, G; Lamberts, Le; Garcia, C; Ameye, L; Stroobants, S; Huizing, M; Aftimos, Pg; Tol, J; Oyen, W; Wana, Z; van Dongen, Gams; Hoekstra, Os; Schroder, Cp; Gaye, J; Menke, Cw; Guiot, T; Brouwers, Ah; Awada, A; de Vries, Ege; Flamen, P
Link alla scheda completa:
Pubblicato in: